Atlas Trials

Safety of Intrathecal Riluzole in Patients With Amyotrophic Lateral Sclerosis

Clinical trial NCT07093268 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07093268
Sponsor
Brain Trust Bio
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Amyotrophic Lateral SclerosisMotor Neuron Disease
Start date
2025-08-15
Primary completion
2026-06-15
Enrollment
10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.